In the past one year, the stock has fallen 2.32% while the benchmark Sensex has risen 8.65% during the same period.

On the technical front, the stock's RSI (relative strength index) stood at 28.39. The RSI oscillates between zero and 100. Traditionally, the RSI is considered overbought when above 70 and oversold when below 30.

The stock was trading below its 50-day, 100-day and 200-day simple moving average (SMA) placed at 838.12, 898.80 and 841.21, respectively.

Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.

On a consolidated basis, Anupam Rasayan India reported 108.2% surge in net profit to Rs 46.10 crore in Q4 FY22 from Rs 22.14 crore registered in Q4 FY21. Net sales grew 16.8% to Rs 317.24 crore in Q4 FY22 over Rs 271.67 crore in Q4 FY21.

The company's board will meet on 24 May 2022 to consider raising funds through issue of equity shares, and or bonds. This may include foreign currency convertible bonds/debentures/non-convertible debt instruments along with warrants/convertible debentures/securities and/or any other equity based instruments/securities by way of qualified institutions placement or rights issue or preferential allotment, or through any other permissible mode or any combination thereof of any of the above.